Correction: CBL Is Frequently Altered in Lung Cancers: Its Relationship to Mutations in MET and EGFR Tyrosine Kinases.
Main Authors: | Yi-Hung Carol Tan, Soundararajan Krishnaswamy, Suvobroto Nandi, Rajani Kanteti, Sapana Vora, Kenan Onel, Rifat Hasina, Fang-Yi Lo, Essam El-Hashani, Gustavo Cervantes, Matthew Robinson, Han-Shui Hsu, Stephen C. Kales, Stanley Lipkowitz, Theodore Karrison, Martin Sattler, Everett E. Vokes, Yi-Ching Wang, Ravi Salgia |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3025517 |
Similar Items
-
Enigma prevents Cbl-c-mediated ubiquitination and degradation of RETMEN2A.
by: Stephen C Kales, et al.
Published: (2014-01-01) -
Differential responsiveness of MET inhibition in non-small-cell lung cancer with altered CBL
by: Yi-Hung Carol Tan, et al.
Published: (2017-08-01) -
Loss of function Cbl-c mutations in solid tumors.
by: Silvano Rakeem Daniels, et al.
Published: (2019-01-01) -
The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic target.
by: Benjamin D Ferguson, et al.
Published: (2013-01-01) -
Cbl-c ubiquitin ligase activity is increased via the interaction of its RING finger domain with a LIM domain of the paxillin homolog, Hic 5.
by: Philip E Ryan, et al.
Published: (2012-01-01)